Deutsche Bank Portfolio holdings
Deutsche Bank AG, founded in 1870 to finance German exports and headquartered in Frankfurt, Germany, is a leading global investment bank with a significant presence in commercial banking, wealth management, and asset management, managing billions in assets across Europe, the Americas, and Asia. Known for its expertise in trading, corporate finance, and mergers and acquisitions, it serves corporations, governments, and institutional clients, though it has faced challenges, including hefty fines and restructuring efforts following the 2008 financial crisis and subsequent scandals. Under CEO Christian Sewing since 2018, the bank has shifted focus toward cost-cutting, digital transformation, and strengthening its core European operations, while its asset management arm, DWS, oversees hundreds of billions in investments. Despite a turbulent past, Deutsche Bank remains a key player in global finance, balancing its legacy with efforts to adapt to a rapidly evolving industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$437M |
| 2 |
TechnipFMC
FTI
|
+$400M |
| 3 |
Qiagen
QGEN
|
+$318M |
| 4 |
Amazon
AMZN
|
+$258M |
| 5 |
Constellation Brands
STZ
|
+$238M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$362M |
| 2 |
QGENF
QIAGEN NV
QGENF
|
+$278M |
| 3 |
Kinder Morgan
KMI
|
+$267M |
| 4 |
Mid-America Apartment Communities
MAA
|
+$235M |
| 5 |
Regency Centers
REG
|
+$160M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.07% |
| 2 | Healthcare | 12.28% |
| 3 | Financials | 12.07% |
| 4 | Industrials | 9.78% |
| 5 | Consumer Discretionary | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Wave Life Sciences
WVE
$1.12B
| $154K | ﹤0.01% |
5,647
+648
| +13% | +$18.1K |
|
3527
Village Super Market
VLGEA
$657M
| $153K | ﹤0.01% |
5,845
-22,006
| -79% | -$640K |
|
|
SYT
3528
DELISTED
Syngenta Ag
SYT
| $153K | ﹤0.01% |
1,740
+400
| +30% | +$34.3K |
|
3529
BCB Bancorp
BCBP
$179M
| $152K | ﹤0.01% |
9,188
-9,018
| -50% | -$132K |
|
3530
Flexible Solutions
FSI
$64.6M
| $152K | ﹤0.01% |
103,809
-35,005
| -25% | -$51.1K |
|
|
URG
3531
Ur-Energy
URG
$469M
| $152K | ﹤0.01% |
231,700
+31,700
| +16% | +$23.5K |
|
|
RETA
3532
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $152K | ﹤0.01% |
6,745
+3,510
| +109% | +$86.7K |
|
3533
CALL
Chevron
CVX
$382B
| $151K | ﹤0.01% |
1,416
-10,538
| -88% | -$1.18M |
|
3534
Haverty Furniture Companies
HVT
$418M
| $151K | ﹤0.01% |
6,305
-10,001
| -61% | -$229K |
|
3535
Lifecore Biomedical
LFCR
$162M
| $151K | ﹤0.01% |
12,820
-11,644
| -48% | -$147K |
|
3536
QuidelOrtho
QDEL
$1.13B
| $151K | ﹤0.01% |
6,678
-21,736
| -76% | -$449K |
|
3537
CRISPR Therapeutics
CRSP
$4.69B
| $150K | ﹤0.01% |
+6,900
| New | +$135K |
|
3538
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.67B
| $150K | ﹤0.01% |
10,301
| – | – |
|
3539
Omeros
OMER
$845M
| $150K | ﹤0.01% |
9,963
-16,730
| -63% | -$183K |
|
3540
PUT
Corpay
CPAY
$25.7B
| $150K | ﹤0.01% |
+993
| New | +$156K |
|
|
RCM
3541
DELISTED
R1 RCM Inc. Common Stock
RCM
| $150K | ﹤0.01% |
+48,704
| New | +$139K |
|
3542
Pure Cycle
PCYO
$255M
| $149K | ﹤0.01% |
26,944
-2,722
| -9% | -$14.5K |
|
3543
TG Therapeutics
TGTX
$8.19B
| $148K | ﹤0.01% |
12,794
-14,958
| -54% | -$107K |
|
|
ELEC
3544
DELISTED
Electrum Special Acquisition Corporation
ELEC
| $148K | ﹤0.01% |
15,000
| – | – |
|
3545
Orion Group Holdings
ORN
$368M
| $147K | ﹤0.01% |
19,883
+1,785
| +10% | +$16.9K |
|
3546
Luxfer Holdings
LXFR
$456M
| $146K | ﹤0.01% |
12,010
-2,773
| -19% | -$31.6K |
|
3547
PUT
Qualcomm
QCOM
$164B
| $146K | ﹤0.01% |
2,560
-3,292
| -56% | -$191K |
|
|
NUTR
3548
DELISTED
Nutraceutical International Co
NUTR
| $146K | ﹤0.01% |
4,727
-147
| -3% | -$4.98K |
|
|
MEET
3549
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $146K | ﹤0.01% |
25,099
+1,387
| +6% | +$7.04K |
|
|
PZN
3550
DELISTED
Pzena Investment Management, Inc. Class A
PZN
| $145K | ﹤0.01% |
14,900
-3,590
| -19% | -$36.4K |
|
Similar funds
Deutsche Bank's Q1 2017 Portfolio in Review
As of Q1 2017, Deutsche Bank held 5,411 positions worth $135B, up 8.9% from $124B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Deutsche Bank's Q1 2017 filing shows 379 new, 1,907 increased, 2,330 reduced and 372 closed positions. Its largest new stake was Qiagen: 10,301,334 shares worth $316M. The largest sale was St Jude Medical, an estimated $362M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.
- Deutsche Bank's largest Q1 2017 buy was Qiagen: 10,301,334 shares worth $316M.
- Deutsche Bank added most to NXP Semiconductors in Q1 2017, an estimated $437M increase.
- Deutsche Bank's biggest Q1 2017 reduction was Kinder Morgan, cutting an estimated $267M.
- Deutsche Bank fully exited St Jude Medical in Q1 2017, selling an estimated $362M.
- Deutsche Bank's ten largest holdings make up 11% of its $135B portfolio in Q1 2017.
- Deutsche Bank opened 379 new positions and closed 372 in Q1 2017.
- Deutsche Bank's portfolio value rose 8.9% quarter-over-quarter to $135B.
Based on Deutsche Bank's 13F filing for Q1 2017, filed 15 May 2017.